Contraindicated in patients whose chronic myel-ogenous leukemia has demonstrated
prior resistance to druq. Also contraindicated in patients with chronic Ivmphocvtic leukemia or acute leukemia and n those in blastic crisis of chronic myelogenous leukemia. |